Locations
Bayer Canada
Latest News
Bayer Crop Science Canada Expands Herbicide Solutions Huskie® PRE and Velocity® m3 in Eastern Canada
Bayer receives marketing authorization in Canada for JIVI® (Antihemophilic Factor [Recombinant, B-domain deleted, PEGylated]) in pediatric patients 7 to under 12 years of age with hemophilia A (congenital Factor VIII deficiency)
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
Health Canada grants marketing authorization for an additional indication of Bayer’s NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC)
Advance Your Career
Our Businesses
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.